The Safety of a Therapeutic Product Composed of a Combination of Stem Cell Released Molecules from Adipose Mesenchymal Stem Cells and Fibroblasts
The paper evaluates the safety of a stem cell-derived therapeutic product containing molecules from adipose mesenchymal stem cells and fibroblasts through in vitro, in vivo, and human skin sensitivity tests, finding it to have an excellent safety profile.
bioRxiv · Feb 14, 2020Bioengineering